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INTRODUCTION 
Ayurveda is a rich indigenous wisdom of India, 
becoming a part of global medicine today. Rasa 
Shastra is a branch of Ayurveda with its unique 
heritage of herbo-mineral drugs in treating the 
diseases. These herbo-mineral drugs have several 
indications  where   the   same   drug   acts  differently  
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based on the Dravyas  used in its pharmaceutical 
method of preparation. 
Kāśīśa  (Green vitriol), one among the Uparasa, is a 
mineral compound containing  Iron, composed of 
Ferrous Sulphate (FeSO4.7 H2O).[1] The Rasashastra 
texts have elaborated  description of Kāśīśa and its 
broad spectrum of therapeutic efficacy  in the 
management  of  numerous ailments when 
administered after proper purification and 
incineration of the drug. Therapeutically  Kāśīśa  
Bhasma is indicated  in Netra Rogas (eye diseases), 
Pandu (Anaemia), Switra (leukoderma), Mutrarogas 
(dysuria), Krimi (helminthiasis,) Jwara (fever), 
Pleehagada (Splenomegaly), Kastartava 
(Amenorrhea).[2] Classical Texts like Sushrutha 
Samhitha,[3] Bhava Prakasha,[4] Ayurveda Prakasha[2] 
cited Kāśīśa  in  Mutrakruchra  and Ashmari 
(Urolithiasis),  the  unexplored  potential of this drug. 
Urolithiasis, the third most prevalent  disease 
characterised by the formation of stone in the urinary 
A B S T R A C T  
Kāśīśa (Ferrous Sulphate, Fe2SO4.7H20),  is among the most commonly used mineral drug in 
Ayurveda, and has been specifically indicated in Mutrashmari. Urolithiasis, (Mutrashmari in Ayurveda) 
is the third most common urinary system disorder globally with high recurrence rate.  The present 
study is to determine the underlying mechanism of Kāśīśa Bhasma as lithotriptic drug in animal 
model. Ethylene glycol (0.75% v/v) induced urolithiasis model was used to study the lithotriptic 
activity of Kāśīśa Bhasma in Wistar  albino rats. 30 rats were divided into five groups and were 
allocated interventions accordingly. Two trial drug groups were given single and double doses of 
Kāśīśa Bhasma (150mg/kg & 300mg/kg respectively), and were compared against the standard 
control group (Tab. Cystone 750mg/kg), administered for 14 days. Relevant biochemical assay and 
histopathological analysis was done and analysed. In vivo study revealed, Kāśīśa Bhasma 
administered at 300mg/kg b.w. was associated with better lithotriptic activity. The results showed 
significant reduction in  calcium oxalate deposits in the kidneys, restoring  the elevated values of  
serum Creatinine, BUN, uric acid and  urine parameters like calcium, phosphate and oxalate while also 
maintaining optimal urine pH when compared to negative control. The lithotriptic activity of Kāśīśa 
Bhasma was found to be corresponding to that of standard drug Tab Cystone.   
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tract.[5] Abundance of promoters and unavailability of 
inhibitors leads to the formation of stones in the 
urinary tract. The geographical, climatic, ethnic, 
dietary, genetic factors & underlying medical 
conditions, and modern lifestyles i.e. industrialization 
and malnutrition play a vital role in occurrence and 
relapse of urinary stones. Approximately 2 million 
people are affected every year in India, with the stone 
belt showing most prevalence - Gujarat, Maharashtra, 
Punjab, Rajasthan, Delhi, Haryana, parts of North 
East.  An analysis from India shows an increase from 
0.9% to 9.0% over 20 years, where 12% of the 
population is expected to have urinary calculi, out of 
which 50% may end up with as  multiple infections 
and haemorrhage, chronic kidney disease or end 
stage renal disease.[6] 
The major treatment modalities in the conventional 
medicine for Urolithiasis are dietary management, 
Medical expulsive therapies, and advanced surgical 
interventions which have their own downsides and 
incompetent in preventing its recurrence. The over 
use of the synthetic drugs, or surgical interventions 
results in  higher incidence of adverse drug reactions 
or events, which has motivated humans to return to 
nature for safe  effective and inexpensive remedies. 
In Ayurveda, Urolithiasis is co-related to Mutrashmari, 
one among the Astamahagadhas,[7] affecting one of 
the Trimarmas - Basti. Acharyas opined before opting  
surgical interventions one should try with oral 
medications which possesses the properties that 
facilitates the elimination of the urinary stones.  
In  the present work, an attempt has been made to 
determine the lithotriptic effect of  Kāśīśa  Bhasma  in 
the experimental model. 
MATERIALS AND METHODS 
Ethylene glycol induced lithiasis study design  was 
used to assess the lithotripsic activity in Wistar albino 
rats. The  calculi was induced by adding Ethylene 
Glycol (EG) to the drinking water to a final 
concentration of 0.75%.  
The acclimatized animals were divided into 5 groups, 
from Group I to Group V, each with 6 rats and 
urolithiasis (stone) was induced in all the groups 
except Group-I as it was reserved as “Normal control”. 
Group II, animals received 0.75% ethylene glycol in 
drinking water ad libitum for 28 days and served as 
the Disease control. The G-III group animals received 
0.75% ethylene glycol in drinking water ad libitum 
along with standard drug -tab  Cystone 750 mg/kg 
body weight, from 15th day till 28th day. G-IV animals 
treated with Kāśīśa Bhasma 150 mg/kg + 0.75% 
ethylene glycol in drinking water ad libitum and G-V 
group animals received 0.75% ethylene glycol in 
drinking water ad libitum, treated with Kāśīśa Bhasma 
300 mg/kg  body weight orally from  15th to 28 days. 
Group Treatment Dose 
1. Normal control - 
2. Ethylene Glycol 0.75%v/v in drinking 
water 
3. Ethylene glycol + 
Cystone 
0.75%v/v +  750mg/kg 
4. Ethylene Glycol+ 
Kāśīśa Bhasma 
single dose 
0.75%v/v + 150mg/kg 
5. Ethylene Glycol + 
Kāśīśa Bhasma 
double dose 
0.75%v/v + 300mg/kg 
Collection of Raw materials 
Raw Kāśīśa  was procured from a genuine supplier 
(Amruth Kesari Depot, Bangalore ) and authenticated 
as per their Grahya Lakshana (accepted characters - 
the Pushpa Kāśīśa is small crystalline form with bright 
green color used for medicinal purpose.) specified in 
the authoritative texts of Rasa-Shastra.[8]  
Preparation of Kāśīśa  Bhasma  
Bhasma was prepared in Rasashala, Department of 
Rasashastra and Bhaishajya Kalpana, RAMC. The 
Shodhana ( Purification) of the Ashoditha Kāśīśa  
(500gms)  was carried out by subjecting it to Swedana 
in Dolayantra with  Shwetha Bhringaraja Swarasa 
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(1700ml) for 3 hours.[2] This was later dried to get 
crystalline form of Shodhitha Kāśīśa. This was 
triturated with Nimbu Swarasa and Chakrikas were 
prepared, kept in a Sharava Samputa subjected to 
Marana (incineration) using Horizontal electrical 
muffle furnace[9] at temperature of 645°C. The 
incineration  process was repeated 5 times till  Kāśīśa  
Bhasma was obtained. (Niramlata - Bhasma Lakshana 
of Kāśīśa - sour taste of Kāśīśa was not appreciated). 
Animals 
Wistar albino rats were housed in Polypropylene 
cages at 23°± 2 C, humidity 55 ± 5% and were kept on 
a 12h light/dark cycle. They were fed with standard 
Pelleted rodent feed (VRK nutrition solutions) and 
water ad libitum and acclimatized for 15 days before 
the study. Experimental protocol reported in this 
study was approved by the Institutional Animal Ethical 
Committee of CPCSEA, Govt. of India (IAEC- Approval 
No Invivo/082 on 30-8-2019) and carried out 
according to Organisation for Economic Cooperation 
Development (OECD) guidelines. 
Chemicals and drugs 
Ethylene glycol (0.75% v/v) were purchased from S D 
fine chemicals, Bangalore. Standard drug was 
purchased from Himalaya Herbal Healthcare, 
Bangalore. Demineralized water and analytical grade 
chemicals/solvents were procured from local market. 
Drug administration 
Cystone tablet and Kāśīśa  Bhasma were administered 
orally through stainless steel oral tube. Kāśīśa  
Bhasma  was mixed with 0.25% of gum acacia solution  
for preparing the test doses. 
Acute toxicity assay 
Acute toxicity study was performed on female 
Sprague Dawley rats by using fixed dose method as 
per OECD guideline 420. In this study, a sighting dose 
of 300 mg/kg was used, and no adverse signs were 
found. Subsequently additional doses of 1000 and 
2000 mg/kg were used. Total of 5 animals were used 
for each dose and was observed for 14 days. No 
clinical signs/adverse effects or death occurred in any 
of the doses tested. 
Evaluation of Lithotriptic activity of Kāśīśa  Bhasma 
on ethylene glycol induced albino rats  
Ethylene glycol induced lithiasis study design  was 
used to assess the lithotripsic  activity in Wistar albino 
rats. The calculi was induced by adding Ethylene 
Glycol (EG) to the drinking water to a final 
concentration of 0.75% (day 1 to day 14-induction 
period). 
The acclimatized animals were divided into 5 groups, 
from Group I to Group V, each with 6 rats and 
urolithiasis (stone) was induced in all the groups 
except Group-I as it was reserved as “Normal control”. 
Group II, animals received 0.75% ethylene glycol in 
drinking water ad libitum for 28 days and served as 
the Disease control. The Group-III animals received 
0.75% ethylene glycol in drinking water ad libitum 
along with standard drug Tab.  Cystone 750 mg/kg 
body weight, from 15th day till 28th day (treatment 
period). Group-IV animals treated with Kāśīśa Bhasma 
150 mg/kg + 0.75% ethylene glycol in drinking water 
ad libitum and Group-V group animals received 0.75% 
ethylene glycol in drinking water ad libitum, treated 
with Kāśīśa Bhasma 300 mg/kg  body weight  orally 
from  15th to 28th day. 
Urine and serum analysis was done at the end of the 
study. The blood sample (1ml) was collected on 28th 
day from each animal through retro-orbital plexus 
under anaesthetic conditions. Urine samples were 
collected through metabolic cage on 28th day. 
Biochemical investigations of calcium, oxalate, 
magnesium, phosphate, and pH from urine samples 
and BUN, Creatinine, uric acid from retro orbital 
artery blood samples was performed. 
Histopathological study was performed by isolating 
both kidneys for detecting the calculi in kidneys . 
Histopathology of harvested kidney section and 
staining method 
Histopathological study of the harvested kidney 
section was carried out to detect the outcome of 
Kāśīśa   Bhasma on the calculi in kidneys and also to 
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know its effect on the internal structures of the kidney 
which shall give information about efficacy of the drug 
as well as its toxicity. This was carried out as per 
standard protocols. Staining of the kidney section was 
carried out as per the standard techniques of 
histology. 
Statistical analysis 
The urinary and blood parameters data were 
recorded, calculated  and expressed as Mean ± SEM. 
The results  were analysed  using one-way ANOVA 
followed by Dunnett’s multiple comparison test. P 
values <0.05 were considered as statistically 
significant.  
RESULTS 
Kāśīśa  Bhasma in double dose has shown significant 
decrease in urine calcium, urine oxalate, urine 
phosphate and urine pH when compared with 
negative control. 
In serum biochemistry the Kāśīśa Bhasma has shown 
significant decrease in Blood Urea Nitrogen (BUN), 
Serum Creatinine and Serum uric acid when compared 
with negative control. 
Histopathological study 
Kidneys of all animals harvested after 28 days were 
subjected to histopathological studies.  
Histopathology of Kidney, confirms the absence of  
stones and associated relevant abnormalities in 
normal control animals (Group I). A significant (P< 
0.001) Calcium Oxalate  crystal deposition was 
observed in calculi-induced group II. The associated 
abnormalities such as marked inflammation of renal 
tissue along with proximal tubules dilation and 
deposition of the intratubular and interstitial crystal 
inside the tubules was a found as a characteristic sign 
of calculi development. Both, Cystone treated and 
Kāśīśa Bhasma double dose treated showed  very few 
areas of inflammatory cells and rare deposition of the 
intratubular and interstitial crystals. 
Urine biochemistry 
From the urine analysis it was found that the levels of 
calcium, oxalate and phosphate were high in the 
disease induced animals,with mean ± SEM 
9.609±0.719, 3.122±0.092 and 10.024±0.174, where 
as the levels of these ions were found to be 
significantly less (p < 0.05) in the urine samples of the 
animals treated with the  Double dose of Kāśīśa  
Bhasma.(Table 1) 
Graph 1: Urine Oxalates  
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Oxalates  values in Ethylene Glycol  treated animals 
was found to be elevated with mean ± SEM of 3.03 
±0.092. Rats treated with Kāśīśa Bhasma 300mg/kg  
and 150mg/Kg showed significant reduction in 
Oxalate values  levels with mean ± SEM and 
significance of 1.18± 0.029 and p<0.005 & 3.02 ± 
0.063 and p<0.05, in minimum and maximum dose  
rats respectively. Cystone treated rats also showed 
substantial decrease of oxalates  with mean ± SEM of 
0.40 ± 0.013 and p<0.005.(Graph1) 
Graph 2: Urine Calcium   
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Calcium   values in Ethylene Glycol  treated animals 
was found to be elevated with mean ± SEM of  8.89 
±0.0719.Rats treated with Kāśīśa Bhasma 300mg/kg  
and 150mg/Kg showed significant reduction in 
calcium  values  levels with mean ± SEM and 
significance of 4.12± 0.128 and p<0.005 & 6.86 ± 
0.241 and p<0.05, in minimum and maximum dose  
rats respectively. Cystone treated rats also showed 
substantial decrease of oxalates  with mean ± SEM of 
3.48 ± 0.215 and p<0.005. (Graph2) 
Graph 3: Urine phosphate  
Phosphate
Co
nt
ro
l
Et
hy
el
en
e 
G
ly
co
l
St
d 
+ 
EG
EG
 +
 K
B1
50
m
g
EG
 +
 K
B3
00
m
g
0
2
4
6
8
10
**
***
***
Groups
m
g
/d
l
 
Phosphate   values in Ethylene Glycol  treated animals 
was found to be elevated with mean ± SEM of 9.85 
±0.174.Rats treated with Kāśīśa Bhasma 300mg/kg  
and 150mg/Kg showed significant reduction in 
Phosphate values  levels with mean ± SEM and 
significance of 4.03 ± 0.127 and p<0.005 & 6.02 ± 
0.067 and p<0.05, in minimum and maximum dose  
rats respectively. Cystone treated rats also showed 
substantial decrease of Phosphate   with mean ± SEM 
of 3.47± 0.217 and p<0.005.(Graph 3) 
However, in Cystone tablets & Kāśīśa Bhasma double 
dose treatments, there was an increased degree of 
reduction in the levels of urine calcium, oxalate and 
phosphate. (P< 0.05) 
The pH of urine intreated animals with Kāśīśa  
Bhasma was found to be maintained at normal urine 
pH (6.64 ± 0.049 ) unlike the diseased group (8.03 
±0.184). (Graph 4) 
Graph 4: Urine pH  
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**p<0.05  ***p<0.005 versus group-II 
Urine pH values in Ethylene Glycol  treated animals 
was found to be elevated with Mean ± SEM of 8.03 
±0.184. Rats treated with Kāśīśa Bhasma 300mg/kg  
and 150mg/Kg showed significant reduction in pH 
values  levels with mean ± SEM and significance of 
6.64 ± 0.049 and p<0.005 & 7.03 ± 0.109 and p<0.05, 
in minimum and maximum dose  rats respectively. 
Cystone treated rats also showed substantial decrease 
of pH  with mean ± SEM of 6.68 ± 0.061 and p<0.005. 
Serum analysis 
On  28thday, Serum analysis was carried out to know 
the levelsof creatinine, uric acid  and BUN. It was 
found that creatinine, uric acid  and BUN values were 
more in case of disease induced animals than the 
normal rats and were significantly reduced (p < 0.05) 
in treated animals. (Table1) 
In serum analysis, BUN  values in Ethylene Glycol  
treated animals was found to be elevated with mean 
± SEM of 32.70 ±0.258. Rats treated with Kāśīśa 
Bhasma 300mg/kg  and 150mg/Kg showed significant 
reduction in BUN values  levels with mean ± SEM and 
significance of 23.13± 0.278 and p<0.005 & 28.12 ± 
0.346 and p<0.05, in minimum and maximum dose  
rats respectively. Cystone treated rats also showed 
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substantial decrease of BUN  with mean ± SEM of 
21.65 ± 0.246 and p<0.005. (Graph 5) 
Graph 5:  Serum BUN 
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Creatinine  values in Ethylene Glycol  treated animals 
was found to be elevated with mean ± SEM of 0.90 ± 
0.048. Rats treated with Kāśīśa Bhasma 300mg/kg  
and 150mg/Kg showed significant reduction in 
Creatinine values  levels with mean ± SEM and 
significance of 0.74 ± 0.021 and p<0.005 & 0.85 ± 
0.022 and p<0.05, in minimum and maximum dose  
rats respectively. Cystone treated rats also showed 
substantial decrease of Creatinine  with mean ± SEM 
of 0.75± 0.018 and p<0.005. (Graph 6) 
Graph 6:  Serum Creatinine  
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Uric acid  values in Ethylene Glycol  treated animals 
was found to be elevated with mean ± SEM of 7.72± 
0.183. Rats treated with Kāśīśa Bhasma 300mg/kg  
and 150mg/Kg showed significant reduction in Uric 
acid values  levels with mean ± SEM and significance 
of 5.40± 0.134 and p<0.005 & 6.75 ± 0.177 and 
p<0.05, in minimum and maximum dose  rats 
respectively. Cystone treated rats also showed 
substantial decrease of Uric acid  with mean ± SEM of 
5.18± 0.194 and p<0.005. (Graph 7) 
Graph 7:  Serum Uric acid  
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**p<0.05  ***p<0.005 versus group-II 
Histopathological images of Kidney tissues 
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Disease control 
 
Cystone 
 
Single dose 
 
Double dose 
 
Table 1: Estimation of Serum and Urine Analysis of  normal and Lithotriptic activity in Rats 
Group Groups BUN (mg/dl) Creatinine 
(mg/dl) 
Uric acid 
(mg/dl) 
Oxalate 
(mg/dl) 
Calcium 
(mg/dl) 
Phosphate 
(mg/dl) 
pH 
Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM 
1. Control 20.16 
 
1.54
9 
0.62 0.03
2 
5.25 0.14
5 
0.39 0.01
6 
2.745 0.11
5 
3.58 0.05
4 
6.43 0.04
2 
2. Ethylene Glycol 32.50 0.25
8 
0.90 0.04
8 
7.72 0.18
3 
3.03 0.09
2 
8.89 0.71
9 
9.85 0.17
4 
8.03 0.18
4 
3. STD (Cystone) + 
Ethylene Glycol 
21.65*
** 
0.24
6 
0.75** 0.01
8 
5.18**
* 
0.19
4 
0.40*
** 
0.01
3 
3.48*
** 
0.21
5 
3.47*
** 
0.21
7 
6.68*
** 
0.06
1 
4. Ethylene Glycol 
+ Kāśīśa  
Bhasma single 
dose 
(150mg/kg) 
28.12*
* 
0.34
6 
0.85 0.02
2 
6.75** 0.17
7 
3.02* 0.06
3 
6.86*
* 
0.24
1 
6.02*
* 
0.06
7 
7.03*
* 
0.10
9 
5. Ethylene Glycol 
+ Kāśīśa  
Bhasma double 
23.13*
** 
0.27
8 
0.74** 0.02
1 
5.40**
* 
0.13
4 
1.18*
** 
0.02
9 
4.12*
** 
0.12
8 
4.03*
** 
0.12
7 
6.64*
** 
0.04
9 
Dr. Kusuma TV et al. An experimental evaluation of the Lithotriptic Activity of Ayurvedic drug Kāśīśa Bhasma 
ISSN: 2456-3110                                                   ORIGINAL ARTICLE Sept-Oct 2020 
 
Journal of Ayurveda and Integrated Medical Sciences | Sept - Oct  2020 | Vol. 5 | Issue 5 203 
 
dose 
(300mg/kg) 
Values given are mean ± S.E.M. (n = 6).**p<0.05  ***p<0.005 versus  group-II 
DISCUSSION 
Urolithiasis is seemingly disturbing mankind since 
ages and is said to be a cause for renal failure if left 
untreated. Surgery is considered the best option 
when the other system of medications fail. There is a 
need to explore an effective  drug  from the ancient 
treasure of herbo mineral formulations. Kāśīśa  
Bhasma is a herbo mineral drug which has been 
indicated to treat Mutrashmari which ought to be 
analysed. The study is to evaluate the lithotriptic 
activity of Kāśīśa  Bhasma in invivo model on calculi 
induced wister albino rats by Ethylene glycol (0.75% 
v/v) for 28 days. 
The drug with multiple mechanism which breaks the 
pathogenesis of  Urolithiasis and also  inhibits stone 
formation had to be selected. (Table 2) 
Ayurveda emphasis on Doshahara Chikitsa as line of 
treatment.  Kapha and Vata Prakopakara Aahara and 
Vihara results in formation of Ashmari. Ashmari is a 
Tridoshaja Vyadhi with predominance of Kapha  
associated with  Vata Dosha. Apana Vayu responsible 
for act of micturition is affected in its major Stana i.e. 
Kati and  Basti giving rise to urolithiasis.  
In Mutraashmari, Kshara (medicated alkali 
preparation) and use of Ushna Tiksna Dravyapana is 
advisable.[10] Kāśīśa Bhasma is a herbo mineral 
preparation where Bhringaraja Swarasa[11] and Nimbu 
Swarasa[12] are the ingredients of its preparation 
having the Ushna Teekshna Gunas. 
Kāśīśa  has the properties like Amla, Kashaya and 
Tikta Rasa, with Ushna Veerya, Katu Vipaka. The 
Karmukata or action of Kāśīśa Is Kapha Vatahara, 
Balya, Yakruth Pleeha Vikarahara, Ashmarighna and 
Mutra Kricharahara. 
The actions of Bhasma  can be interpreted as follows. 
The Kapha Vatahara properties of Kāśīśa, Bhringaraja 
and Nimbu drugs help pacifying the aggravated  
Doshas of Ashamari i.e.,  Kapha and Vata. By virtue of 
its Laghu and Ruksha Guna, Amla, Katu and Tikta 
Rasa, Ushna Veerya, Kāśīśa Bhasma may also exhibit 
"Lekhana" property and dissolve the stones in urine.  
Kāśīśa, Bhringraja and Nimbu are drugs known for 
Yakruth Vikaras (Liver disorders). They help in 
rectifying the Agni, enhancing the Protein  
metabolism in the liver, as proteins in the urine also 
play significant role in crystallization of stones in urine 
and they may regulate the crystalloid colloid balance 
of urine composition. (Table 2) 
Kāśīśa is one among the Ushakaadi Gana Dravyas[4] 
i.e., it destroys  Kapha, it cures Ashmari Sharkara 
(stone gravels / urinary calculi) and Mootrakruchra 
(dysuria). That is, it might act as diuretic and 
Ashmarighna so that  the stone might be dissolved, 
thus reducing the  size of the Ashmari and expelled  
out from the body.  
The Gunas of Bhasma here  decodes Samprapti 
(etiopathogenesis) of Mutrashmari, i.e,  the Kapha-
Vataja Sangha in Mutravaha Srotas resulting in 
expulsion of calculi and also may inhibit further stone 
formation. Thus in total this drug has the capacity to 
disintegrate the pathogenesis of the disease 
Mutrashmari. 
Metals such as magnesium, zinc, aluminum, iron and 
copper may act as inhibitors of calcium oxalate 
growth at very low concentrations. We may infer from 
this that the iron, copper and zinc  in the form of 
Kāśīśa Bhasma might have acted as inhibitor of the 
calcium oxalates stones.[18]  The Bhasmas are given in 
minimal doses or Alpa Matra, this  serves the purpose 
of supporting   low concentration of the trace 
elements in urine to inhibit stone formation.  
The results of Urine analysis showed increased 
Urinary oxalates in ethylene glycol induced urolithiasis 
rats whereas there was decreased excretion of 
oxalates in Kāśīśa  Bhasma double dose treated rats 
which may be due to inhibition of formation of 
oxalates by the administered drug. The calcium and 
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Phosphate levels were also decreased in the Kāśīśa 
administered rats, while maintaining the pH levels to 
its normal levels. (Table 1) 
The decreased urine flow in the urolithiasis rats, leads 
to increased nitrogenous waste in the blood. The 
Serum analysis of creatinine, BUN and Uric acid were 
also elevated in the ethylene glycol treated rats which 
was reduced in the Kāśīśa Bhasma treated rats, which 
can be interpreted as minimal urine blockage in the 
kidneys due to inhibition of stone forming crystals and 
less damage to kidney tissue. The Histopathological 
report of Kidney revealed there were rare calculi 
crystals in the referred drug treated kidneys when 
compared with the ethylene glycol treated rats. 
Table 2: Multiple mechanisms of desirable Drug 
actions to inhibit stone formation and efficacy  of 
Kāśīśa Bhasma. 
SN  Factors for  inhibiting 
stone formation[13] 
Kāśīśa Bhasma - Drug 
action on Ashmari 
1. Drug should help in 
spontaneous passage 
of calculi by increasing 
urine volume, pH and 
anti-calcifying activity. 
Kāśīśa Bhasma  shows 
the pH of urine is 
maintained at normal 
level and also 
disintegrates the 
stones. 
2. Drug should balance 
the inhibitor and 
promoter of 
crystallization in urine 
and affects the crystal 
nucleation, aggregation 
and growth (Crystal 
inhibition activity)· 
Nimbu Swarasa in 
Kāśīśa Bhasma  
contains citrate which 
prevents the calcium 
ions from combining 
with oxalate to form 
crystals.[14] 
The high potassium 
content of lemon is 
very effective in 
removal of deposits in 
kidneys, urinary 
bladder and its 
disinfectant properties 
help cure infections in 
the urinary system. It 
clears blockage of 
urine due to 
deposition of calcium 
in the urinary tract.[15] 
3. Drug should relieve the 
binding mucin of 
calculi. (Lithotriptic 
activity)· 
Kāśīśa Bhasma and 
Bhringaraja have the 
property of improving 
function of  liver  
where protein 
metabolism takes 
place and thus can  
probably regulates the 
crystalloid colloid 
imbalance in urine  
and improve renal 
function, thus 
prevents recurrence of 
calculi. Drug attributes 
the metabolic 
correction of the 
serum and urinary 
electrolyte levels. 
4.  Drug should regulate 
the crystalloid colloid 
imbalance and improve 
renal function, thus 
prevents recurrence of 
calculi· 
5. Drug should improve 
renal tissue anti-
oxidant status and cell 
membrane integrity 
and prevent recurrence 
(Anti-oxidant activity)· 
Bringaraja and Nimbu 
have anti mirobial, 
anti-inflammatory, 
Analgesic and 
antioxidant 
properties.[16],[17] 
CONCLUSION 
Urinary stone is a multifactorial disorder and needs to 
be treated with a Drug which acts at multiple levels to 
combat it. Acute toxicity study revealed - Kāśīśa  
Bhasma was non toxic. Kāśīśa  Bhasma,  herbo-
mineral drug with its broad spectrum of therapeutic 
benefits has shown significant contribution of 
lithotriptic activity to combat Mutrashmari in the dose 
of 300mg/kg  in ethylene glycol induced urolithiasis 
model. 
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